Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multicenter evaluation of the MicroScan Rapid Gram-Negative Identification Type 3 Panel

S Bascomb1, S L Abbott, J D Bobolis

  • 1Dade MicroScan Inc., West Sacramento, California 95691, USA.

Journal of Clinical Microbiology
|October 8, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preferences for couple-based smoking cessation interventions among couples who smoke: online discrete choice experiment.

Health education research·2025
Same author

Single-cell Transcriptional Analysis of the Cellular Immune Response in the Oral Mucosa of Mice.

bioRxiv : the preprint server for biology·2023
Same author

Shifts in learning assistants' self-determination due to COVID-19 disruptions in Calculus II course delivery.

International journal of STEM education·2021
Same author

Altered subcortical emotional salience processing differentiates Parkinson's patients with and without psychotic symptoms.

NeuroImage. Clinical·2020
Same author

Elderly gynaecological cancer patients at risk for poor end of life care: a population-based study from the Swedish Register of Palliative Care.

Acta oncologica (Stockholm, Sweden)·2020
Same author

A novel treatment of bromelain and acetylcysteine (BromAc) in patients with peritoneal mucinous tumours: A phase I first in man study.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2019
Same journal

Ebola laboratory preparedness at frontline hospitals: can we or can't we?

Journal of clinical microbiology·2026
Same journal

Reporting macrolide-resistant <i>Mycoplasma pneumoniae</i>: a diagnostic obligation?

Journal of clinical microbiology·2026
Same journal

Diagnostic value of HHV-6A/B genotyping in immunocompromised adults.

Journal of clinical microbiology·2026
Same journal

Multicenter performance evaluation of the Simplexa <i>C. auris</i> Direct assay for the detection of <i>Candida auris</i> colonization in bilateral axilla/groin swabs.

Journal of clinical microbiology·2026
Same journal

Comparison of blood culture contamination rates with standard practice versus two blood diversion devices at a single institution.

Journal of clinical microbiology·2026
Same journal

Risk assessment and mitigation of hepatitis C virus RNA carryover contamination in a reflex testing algorithm.

Journal of clinical microbiology·2026
See all related articles

The revised MicroScan Rapid Gram-Negative Identification Type 3 Panel demonstrates high accuracy and reproducibility in identifying gram-negative bacteria. This evaluation confirms its reliable performance across multiple laboratories for clinical microbiology.

Area of Science:

  • Clinical Microbiology
  • Bacterial Identification
  • Diagnostic Technology

Background:

  • Accurate identification of gram-negative bacteria is crucial for effective patient treatment and infection control.
  • Existing identification methods may have limitations in speed, accuracy, or scope.
  • The MicroScan Rapid Gram-Negative Identification Type 3 Panel underwent revisions to improve its performance.

Purpose of the Study:

  • To evaluate the accuracy and performance of the revised MicroScan Rapid Gram-Negative Identification Type 3 Panel.
  • To assess the panel's ability to identify a broad range of gram-negative taxa, including newly added species.
  • To determine the reproducibility of the panel in multicenter settings.

Main Methods:

  • A multicenter evaluation involving efficacy, challenge, and reproducibility testing phases.

Related Experiment Videos

  • Testing utilized a diverse collection of fresh and stock gram-negative isolates.
  • Performance was benchmarked against the API 20E system and conventional tube methods.

    • Main Results:

    • Efficacy phase: 96.8% correct identification for 54 species.
    • Challenge phase: 89.5% correct identification for 247 isolates, including new species.
    • Reproducibility: 99.8% intra- and interlaboratory agreement; 99.9% overall substrate reproducibility.

    Conclusions:

    • The revised MicroScan Rapid Gram-Negative Identification Type 3 Panel provides accurate results for gram-negative bacterial identification.
    • The panel demonstrated high levels of reproducibility in multicenter testing.
    • This updated panel is a reliable tool for clinical microbiology laboratories.